Nature | Vol 577 | 30 January | 676
https://www.nature.com/articles/s41586-020-1935-3
Bing Zhang1, Sai Ma1,2,3, Inbal Rachmin4, Megan He1,5, Pankaj Baral6, Sekyu Choi1, William A. Gonçalves7, Yulia Shwartz1, Eva M. Fast1,8, Yiqun Su4, Leonard I. Zon1,8,9, Aviv Regev2,3,9, Jason D. Buenrostro1, Thiago M. Cunha6,10, Isaac M. Chiu6, David E. Fisher4 & Ya-Chieh Hsu1
1Department of Stem Cell and Regenerative Biology, Harvard University and Harvard Stem Cell Institute, Cambridge, MA, USA. 2Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA. 3Department of Biology and Koch Institute, Massachusetts Institute of Technology, Cambridge, MA, USA. 4Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. 5Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA. 6Department of Immunology, Harvard Medical School, Boston, MA, USA. 7Institute of Biological Science, Federal University of Minas Gerais, Belo Horizonte, Brazil. 8Stem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. 9Howard Hughes Medical Institute, Chevy Chase, MD, USA. 10Center for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil. *e-mail: yachieh_hsu@harvard.edu*
